We are live on ! Find out more
XBIT icon

XBiotech
XBIT

66 hedge funds and large institutions have $56.7M invested in XBiotech in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

190% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 10

18% more funds holding

Funds holding: 56 → 66 (+10)

1.78% more ownership

Funds ownership: 13.71% → 15.49% (+1.8%)

15% less capital invested

Capital invested by funds: $66.6M → $56.7M (-$9.94M)

98% less call options, than puts

Call options by funds: $8K | Put options by funds: $452K

Holders
66
Holders Change
+10
Holders Change %
+17.86%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
29
Reduced
10
Closed
2
Calls
$8K
Puts
$452K
Net Calls
-$444K
Net Calls Change
-$76K

Top Buyers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
+$5.58M
2
Citadel Advisors
Citadel Advisors
Florida
+$762K
3
HF
HRT Financial
New York
+$571K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$535K
5
Northern Trust
Northern Trust
Illinois
+$467K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$1M
2
N
Nuveen
North Carolina
-$563K
3
CS
Credit Suisse
Switzerland
-$350K
4
PPA
Parametric Portfolio Associates
Washington
-$348K
5
JP Morgan Chase
JP Morgan Chase
New York
-$99.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
26
STRS Ohio
Ohio
$265K +$49.4K +3,100 +18%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$211K -$74K -4,647 -22%
Millennium Management
28
Millennium Management
New York
$194K +$239K +15,010 New
VEA
29
Virtus ETF Advisers
New York
$187K +$17.2K +1,078 +8%
TNB
30
Thomasville National Bank
Georgia
$173K – – –
LSA
31
Leonteq Securities AG
Switzerland
$168K – – –
SG Americas Securities
32
SG Americas Securities
New York
$165K +$203K +12,735 New
Morgan Stanley
33
Morgan Stanley
New York
$159K -$10.3K -645 -5%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$157K – – –
VF
35
Virtu Financial
New York
$157K +$193K +12,111 New
SF
36
Synovus Financial
Georgia
$153K – – –
Simplex Trading
37
Simplex Trading
Illinois
$153K +$3.19K +200 +2%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$150K +$558 +35 +0.3%
EMG
39
ETF Managers Group
New Jersey
$146K +$35.8K +2,246 +25%
CANY
40
Caxton Associates (New York)
New York
$134K – – –
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$130K +$160K +10,069 New
Deutsche Bank
42
Deutsche Bank
Germany
$113K -$3.41K -214 -2%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$110K – – –
AIG
44
American International Group
New York
$108K -$1.39K -87 -1%
JP Morgan Chase
45
JP Morgan Chase
New York
$105K -$99.1K -6,222 -43%
Barclays
46
Barclays
United Kingdom
$80K +$67.8K +4,256 +212%
MIM
47
MetLife Investment Management
New Jersey
$76.3K +$93.9K +5,892 New
UBS Group
48
UBS Group
Switzerland
$74K +$32.5K +2,039 +56%
Legal & General Group
49
Legal & General Group
United Kingdom
$65K +$57.7K +3,623 +258%
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$65K +$79.7K +5,000 New
1
2
3

XBIT Hedge Fund Activity: Q3 2021 in Review

66 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q3 2021, worth a combined $56.7M — down 15% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new XBIT positions and 2 closed out — a net gain of 10 holders — while 29 added to existing stakes and 10 trimmed.

The largest buyer was Oracle Investment Management, opening a new position worth an estimated $5.58M. The largest seller was Wells Fargo, cutting an estimated $1M.

  • 66 institutional investors held XBiotech (XBIT) as of Q3 2021, up from 56 in Q2 2021.
  • Funds reported $56.7M of XBiotech stock for Q3 2021, down 15% quarter-over-quarter.
  • 12 funds opened new XBiotech positions in Q3 2021 and 2 closed out, a net change of +10 holders.
  • The largest XBiotech buyer in Q3 2021 was Oracle Investment Management, an estimated $5.58M added.
  • The largest XBiotech seller in Q3 2021 was Wells Fargo, an estimated $1M sold.

Based on aggregated 13F filings for Q3 2021.